Cargando…
The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders
Background: B-Cell Lymphoproliferative Disorders (B-LPDs) are a group of heterogenous disorders characterised by the accumulation of B-cells in peripheral blood, bone marrow, lymph nodes and spleen. They have a variable disease course and outcome and many share similar features making differential d...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563807/ https://www.ncbi.nlm.nih.gov/pubmed/37822353 http://dx.doi.org/10.3389/bjbs.2023.11573 |
_version_ | 1785118413793787904 |
---|---|
author | Al-Zubaidi, Hanaan Kareem Hughes, Stephen Fôn |
author_facet | Al-Zubaidi, Hanaan Kareem Hughes, Stephen Fôn |
author_sort | Al-Zubaidi, Hanaan Kareem |
collection | PubMed |
description | Background: B-Cell Lymphoproliferative Disorders (B-LPDs) are a group of heterogenous disorders characterised by the accumulation of B-cells in peripheral blood, bone marrow, lymph nodes and spleen. They have a variable disease course and outcome and many share similar features making differential diagnosis challenging. Therefore, accurate diagnosis is fundamental in particular for determining treatment options. Immunophenotyping by flow cytometry plays a crucial role in the diagnosis of B-LPDs. However, overlapping immunophenotyping patterns exist and the use of novel monoclonal antibodies has become increasingly important in immunophenotyping analysis. More recently differential expression of CD200 has been reported in various B-LPDs and that CD200 may improve the differentiation between chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL). In this study CD200 expression is evaluated in different B-LPDs. Methods: A total of 100 samples were collected and analysed by immunophenotyping flow cytometry over a period of 1 year (2017–2018), by a panel of monoclonal antibodies including CD200. The percentage of CD200 and its expression intensity was evaluated and compared between different groups of B-LPDs. Results: All of the 50 cases of CLL expressed CD200 with moderate to bright intensity, 6 MCL cases lacked the expression of CD200. Furthermore, all 5 cases of hairy cell leukaemia (HCL) expressed CD200. Out of all B-LPDs evaluated, CD200 expression in HCL cases was noted to be the brightest. The other 39 cases were not found to be B-LPDs. Conclusion: CD200 has an important role in differentiating CLL from MCL, HCL has a consistent bright expression of CD200. By adding CD200 to the combinations of markers in routine testing panel, Immunophenotyping by flow cytometry can be an effective tool in the diagnosis of B-LPDs especially in cases with atypical immunophenotyping pattern. Our result support that CD200 can be added to routine testing panel as it is useful in differentiating them. |
format | Online Article Text |
id | pubmed-10563807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105638072023-10-11 The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders Al-Zubaidi, Hanaan Kareem Hughes, Stephen Fôn Br J Biomed Sci Health Archive Background: B-Cell Lymphoproliferative Disorders (B-LPDs) are a group of heterogenous disorders characterised by the accumulation of B-cells in peripheral blood, bone marrow, lymph nodes and spleen. They have a variable disease course and outcome and many share similar features making differential diagnosis challenging. Therefore, accurate diagnosis is fundamental in particular for determining treatment options. Immunophenotyping by flow cytometry plays a crucial role in the diagnosis of B-LPDs. However, overlapping immunophenotyping patterns exist and the use of novel monoclonal antibodies has become increasingly important in immunophenotyping analysis. More recently differential expression of CD200 has been reported in various B-LPDs and that CD200 may improve the differentiation between chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL). In this study CD200 expression is evaluated in different B-LPDs. Methods: A total of 100 samples were collected and analysed by immunophenotyping flow cytometry over a period of 1 year (2017–2018), by a panel of monoclonal antibodies including CD200. The percentage of CD200 and its expression intensity was evaluated and compared between different groups of B-LPDs. Results: All of the 50 cases of CLL expressed CD200 with moderate to bright intensity, 6 MCL cases lacked the expression of CD200. Furthermore, all 5 cases of hairy cell leukaemia (HCL) expressed CD200. Out of all B-LPDs evaluated, CD200 expression in HCL cases was noted to be the brightest. The other 39 cases were not found to be B-LPDs. Conclusion: CD200 has an important role in differentiating CLL from MCL, HCL has a consistent bright expression of CD200. By adding CD200 to the combinations of markers in routine testing panel, Immunophenotyping by flow cytometry can be an effective tool in the diagnosis of B-LPDs especially in cases with atypical immunophenotyping pattern. Our result support that CD200 can be added to routine testing panel as it is useful in differentiating them. Frontiers Media S.A. 2023-09-26 /pmc/articles/PMC10563807/ /pubmed/37822353 http://dx.doi.org/10.3389/bjbs.2023.11573 Text en Copyright © 2023 Al-Zubaidi and Hughes. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Health Archive Al-Zubaidi, Hanaan Kareem Hughes, Stephen Fôn The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders |
title | The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders |
title_full | The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders |
title_fullStr | The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders |
title_full_unstemmed | The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders |
title_short | The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders |
title_sort | use of cd200 in the differential diagnosis of b-cell lymphoproliferative disorders |
topic | Health Archive |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563807/ https://www.ncbi.nlm.nih.gov/pubmed/37822353 http://dx.doi.org/10.3389/bjbs.2023.11573 |
work_keys_str_mv | AT alzubaidihanaankareem theuseofcd200inthedifferentialdiagnosisofbcelllymphoproliferativedisorders AT hughesstephenfon theuseofcd200inthedifferentialdiagnosisofbcelllymphoproliferativedisorders AT alzubaidihanaankareem useofcd200inthedifferentialdiagnosisofbcelllymphoproliferativedisorders AT hughesstephenfon useofcd200inthedifferentialdiagnosisofbcelllymphoproliferativedisorders |